The Future of Chronic Lymphocytic Leukemia Treatment- Balancing Efficacy, Safety and Cost

A Review of the Mundipharma International Ltd Organised Symposium, at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL), Cologne, Germany, 9th-11th September 2013

Valentin Goede,1 Clemens Wendtner,2 George Follows3

1. Department of Internal Medicine, University Hospital Cologne, Cologne, Germany
2. Chief Physician, Schwabing Hospital, Munich, Germany
3. Consultant Haematologist, Addenbrooke’s Hospital, Cambridge, UK

Acknowledgements: Writing assistance has been provided by Trilogy Writing and Consulting Ltd.
Support: This article has been supported financially by an educational grant from Mundipharma, who have had no editorial input.
Citation: EMJ Oncol. 2013;1:38-47.

Download (PDF, 178KB)

Leave a Reply